Associated Orthodontists of Indiana in Carmel, Indiana

Info
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • Associated Orthodontists of Indiana

  • Dr. Mary E. Brandt, DDS

  • Indiana Restorative Dentistry – Tyler J Thomas DMD MSD

  • Carmel Family Dentistry – Dr. Jessica Worthington

  • David C. Wood Family & Cosmetic Dentistry

  • David C. Wood Family & Cosmetic Dentistry

  • |
    Restless Legs Syndrome Explained: Symptoms, Causes, and Treatments

    “Restless Legs Syndrome Explained: Symptoms, Causes, and Treatments” offers a clear, supportive guide to understanding RLS—an urge to move the legs, often at night, with sensations like tingling or crawling. It covers common triggers and causes (such as iron deficiency, genetics, pregnancy, certain medications, and kidney or nerve conditions), how RLS is diagnosed, and practical self-care steps including consistent sleep routines, gentle exercise and stretching, limiting caffeine/alcohol/nicotine, and using heat, cold, or massage. The article also outlines evidence-based treatments—like iron repletion when low and medications that calm nerve signals—and provides tips for tracking symptoms and knowing when to seek medical help, helping patients and caregivers improve daily comfort and sleep.

  • Aurora Bay Area Prices – BUPRENORPHINE HCL 8 MG SL SUBL is $0.71

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding BUPRENORPHINE HCL 8 MG SL SUBL, which is classified under revenue code 250 and associated with CPT code J0571, the designated fee stands at $0.71. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • How to Vet an Online Compounded GLP-1 Prescription

    FDA’s June 16, 2026 warning-letter wave aimed at telehealth marketing adds a practical question for patients: how do you tell a legitimate compounded GLP-1 prescription from a risky online pitch? Here is what FDA says to check before you pay or use the drug. ([fda.gov](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters))